This is our UK/Europe website. If you are in North America, please click here to visit our other site.

Shopping Basket

Your basket is empty

Currency Settings

In a randomised, controlled, single-blind trial in the UK, patients in the 'active' group received needling at Zanzhu BL-2, Yingxiang L.I.-20 and Hegu L.I.-4 (deqi was obtained and needles retained for five minutes), whilst patients in the control gr


    • Please note that: the most twenty most recent research abstracts are free to view but access to the thousands of items in the archive require a journal subscription .

Not yet subscribed?

Subscribe to the Journal of Chinese Medicine now from only £30.00 per year. Your subscription will include:

Subscribe now